How It Works
The Medicine
The Journey
Our Spaces
Our Doctors
Pricing
The Science
The Neuroscience of Ketamine
Psychedelic Therapy 101
Clinical Research
Ketamine News
Psychedelic Medicine Pipeline
Login
Get Started
Now At-Home & Virtually Guided
Home
How it works
The Medicine
The Journey
Our Spaces
Our Doctors
Pricing
The Science
The Neuroscience of Ketamine
Psychedelic Therapy 101
Clinical Research
Press
Psychedelic Medicine Pipeline
About us
FAQ
Login
Login
Am I a candidate?
Mindbloom in the Press
The Third Wave
Published on
November 20, 2020
Telemedicine, Ketamine Lozenges, and Healing Depression: An Interview with Mindbloom's Dr. Casey Paleos
Women's Health
Published on
September 16, 2020
‘I Started Doing At-Home Guided Ketamine Treatments To Help With My Depression During Quarantine’
The Founder Podcast
Published on
January 12, 2021
Transforming Lives Through Ketamine Therapy
Below The Line
Published on
January 6, 2021
The Innovative Future of Psychedelics — Below the Line
Addicted Mind
Published on
December 18, 2020
Mindbloom & Psychedelic Medicine with Dylan Beynon
Mind Things
Published on
December 1, 2020
Mindbloom CEO/Founder Dylan Beynon - The Lead Domino to Change the World
Load More
Ketamine and Psychedelic Therapy News
The New York Times
Published on
September 4, 2019
Johns Hopkins Opens New Center for Psychedelic Research
National Institute of Mental Health
Published on
August 13, 2019
New Hope for Treatment-Resistant Depression: Guessing Right on Ketamine
Forbes
Published on
June 14, 2019
How Ketamine Opens a New Era for Depression Treatment
Psychiatry Advisor
Published on
March 19, 2019
Ketamine: A Promising Novel Therapy for Anxiety and PTSD
Load More
Next up – The Pipeline
Click anywhere to discover
Press